The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Endotoxemia and gut barrier dysfunction in alcoholic liver disease†
Open accessAbstract
Agrowing body of evidence indicates that endotoxemia is closely associated with alcoholic liver disease (ALD). Endotoxins stimulate different cells in the liver releasing cytokines, chemokines, and reactive oxygen species (ROS) by toll-like receptor-4 (TLR-4)–mediated mechanisms. Intestinal microflora is the source of circulating endotoxins, and the gut barrier dysfunction leading to elevated intestinal permeability is considered the main cause of endotoxemia in ALD. The mechanism of ethanol-induced gut barrier disruption is an active area of investigation. Evidence indicates that intestinal microflora, the metabolism of ethanol, and acetaldehyde-induced cell signaling are involved in ethanol-induced intestinal barrier dysfunction. Recent advances in alcoholic endotoxemia, the mechanism of epithelial barrier disruption, and the factors that prevent alcoholic endotoxemia are discussed in this article. The current understanding of these issues is illustrated in Fig. 1. Diagrammatic representation of ethanol-induced intestinal permeability and endotoxemia. Ethanol in the colonic lumen is metabolized to acetaldehyde by microflora and mucosa. Acetaldehyde disrupts epithelial barrier function and allows the diffusion of bacterial LPS into the portal circulation. In the liver, LPS activates Kupffer cells via an LBP/CD14/TLR-4–dependent mechanism. Abbreviations: ADH, alcohol dehydrogenase; LBP, lipopolysaccharide binding protein; LPS, lipopolysaccharide; NFκB, nuclear factor kappa B; ROS, reactive oxygen species; TLR-4, toll-like receptor 4. Endotoxins are lipopolysaccharides (LPSs) derived from the cell walls of gram-negative bacteria. Dead bacteria and the LPS shed from the cell walls of viable organisms contribute to the circulating endotoxins. Normally, Kupffer cells in the liver detoxify endotoxins by phagocytosis. When the flux of endotoxins overwhelms the phagocytotic capacity of Kupffer cells, the endotoxins spill into the systemic circulation. Endotoxemia is conventionally believed to exist when the plasma endotoxin level rises higher than 2.5 endotoxin units per milliliter. Endotoxemia in ALD was first recognized by the detection of antibodies against Escherichia coli in the plasma of patients with ALD.1 Numerous subsequent studies have demonstrated that the plasma endotoxin level in patients with ALD is several times greater than that in healthy subjects2-7 or in patients with nonalcoholic cirrhosis.4 Endotoxemia was recorded in alcoholics who showed only minimal symptoms of ALD7; therefore, endotoxemia appears to occur early during the pathogenesis of this disease.7 The plasma endotoxin level in normal subjects ranges from 0.3 to 10.4 pg/mL,2-8 whereas the endotoxin level in ALD patients ranges from 8.5 to 206 pg/mL.2-8 Despite the wide variability in endotoxin values, the plasma endotoxin levels in patients with ALD have always been found to be 5- to 20-fold greater than those in normal subjects. Although one study has indicated the existence of a positive correlation between the degree of endotoxemia and the severity of disease,3 other studies have failed to demonstrate such a correlation.7 Endotoxemia in ALD has been confirmed in experimental models of alcoholic liver injury. Plasma endotoxin levels are elevated by acute9, 10 or chronic9, 11-13 ethanol administration, and the levels correlate well with the development of liver injury. The elevation of the plasma endotoxin level with acute ethanol administration indicates that endotoxemia occurs during the early stage of liver damage. Although there exists no single animal model that depicts different stages of ALD, there is a striking agreement between plasma endotoxin levels in patients with ALD and ethanol-fed animals. There is no evidence of species-dependent differences in alcoholic endotoxemia; however, a gender-dependent difference has been observed.12, 14 ADH, alcohol dehydrogenase; AJ, adherens junction; ALD, alcoholic liver disease; EGF, epidermal growth factor; LBP, lipopolysaccharide binding protein; LPS, lipopolysaccharide; MLCK, myosin light chain kinase; NFκB, nuclear factor kappa B; PKC, protein kinase C; PLCγ, phospholipase C-γ; PTPase, protein tyrosine phosphatase; PTP1B, protein tyrosine phosphatase-1B; ROS, reactive oxygen species; TJ, tight junction; TLR, toll-like receptor; ZO-1, zonula occludens-1. The attenuation of alcohol-induced endotoxemia and liver damage by antibiotics indicates that endotoxin plays a crucial role in alcoholic liver damage.15 An emerging body of evidence indicates that LPS and ethanol synergistically affect the liver cells. LPS by itself fails to mimic ethanol-induced steatosis or hepatitis; however, ethanol and LPS together effectively induce liver damage. Ethanol feeding sensitizes the liver to LPS-induced cellular injury in experimental animals16-18 and exacerbates LPS-induced cytokine release in the liver.19 The mechanism of synergism between ethanol and LPS may involve multiple factors, such as down-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight junctions and the molecular basis for regulation of paracellular permeability
Anderson, J. M., & Van Itallie, C. M. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.4.g467 · Cited by 843
Antibiotics prevent liver injury in rats following long-term exposure to ethanol
Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W., & Thurman, R. G. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90027-6 · Cited by 692
Lipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex
da Silva Correia, J., Soldau, K., Christen, U., Tobias, P. S., & Ulevitch, R. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009164200 · Cited by 649
Parlesak, A., Schäfer, C., Schütz, T., Bode, J. C., & Bode, C. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80242-1 · Cited by 647 · cited 1×
“(6) Ethanol at high doses alters the cytoskeletal structure by a nitric oxide–dependent and MLCK-dependent mechanism, (7) which in turn disrupts tight junctions.”
BackgroundHaziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., & Goyert, S. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.2.547 · Cited by 645
Inactivation of Kupffer cells prevents early alcohol-induced liver injury
Adachi, Y., Bradford, B. U., Gao, W., Bojes, H. K., & Thurman, R. G. (1994) · Hepatology · doi:10.1002/hep.1840200227 · Cited by 556
Bode, C., Kugler, V., & Bode, J. C. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80003-x · Cited by 529
Toll–Like Receptor 4 Is Involved in the Mechanism of Early Alcohol–Induced Liver Injury in Mice
Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., & Thurman, R. G. (2001) · Hepatology · doi:10.1053/jhep.2001.25350 · Cited by 488
Ethanol, oxidative stress, and cytokine-induced liver cell injury
Hoek, J. B., & Pastorino, J. G. (2002) · Alcohol · doi:10.1016/s0741-8329(02)00215-x · Cited by 478
Fukui, H., Brauner, B., Bode, J. C., & Bode, C. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90933-3 · Cited by 461 · cited 1×
“(3) Tyrosine phosphorylation of -catenin results in the loss of its interaction with E-cadherin, and (4) the loss of the interaction between E-cadherin and -catenin leads to a loss of the homophilic interaction between extracellular domains of E-cadherin and disruption of adherens junctions.”
Background
Cited by
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,160
The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771
Gut–Liver Axis in Alcoholic Liver Disease
Szabo, G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.042 · Cited by 754
Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120026 · Cited by 628
Pathogenesis of alcoholic liver disease: Role of oxidative metabolism
Ceni, E., Mello, T., & Galli, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17756 · Cited by 521
Manco, M., Putignani, L., & Bottazzo, G. F. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0030 · Cited by 483
Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut
Seki, E., & Schnabl, B. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2011.219691 · Cited by 442
Inflammatory pathways in alcoholic steatohepatitis
Gao, B., Ahmad, M. F., Nagy, L. E., & Tsukamoto, H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.023 · Cited by 392
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice
Ferrere, G., Wrzosek, L., Cailleux, F., Turpin, W., Puchois, V., Spatz, M., Ciocan, D., Rainteau, D., Humbert, L., Hugot, C., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.008 · Cited by 324
The role of alcohol and smoking in pancreatitis
Yadav, D., & Whitcomb, D. C. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.6 · Cited by 313
Toll‐like receptors in alcoholic liver disease, non‐alcoholic steatohepatitis and carcinogenesis
Roh, Y. S., & Seki, E. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12019 · Cited by 301
Inflammation in Alcoholic Liver Disease
Wang, H. J., Gao, B., Zakhari, S., & Nagy, L. E. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-072610-145138 · Cited by 297
Michelena, J., Altamirano, J., Abraldes, J. G., Affò, S., Morales‐Ibanez, O., Sancho‐Bru, P., Dominguez, M., García‐Pagán, J. C., Fernández, J., Arroyo, V., et al. (2015) · Hepatology · doi:10.1002/hep.27779 · Cited by 291
Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease
Wu, X., Fan, X., Miyata, T., Kim, A., Cajigas-Du Ross, C. K., Ray, S., Huang, E., Taiwo, M., Arya, R., Wu, J., et al. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-030435 · Cited by 289
Alcohol, inflammation, and gut-liver-brain interactions in tissue damage and disease development
Wang, H. J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i11.1304 · Cited by 277
van den Munckhof, I. C. L., Kurilshikov, A., ter Horst, R., Riksen, N. P., Joosten, L. A. B., Zhernakova, A., Fu, J., Keating, S. T., Netea, M. G., de Graaf, J., et al. (2018) · Obesity Reviews · doi:10.1111/obr.12750 · Cited by 270
Molecular Mechanism for Adiponectin-dependent M2 Macrophage Polarization
Mandal, P., Pratt, B. T., Barnes, M., McMullen, M. R., & Nagy, L. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.204644 · Cited by 258
The Effect of Inflammatory Cytokines in Alcoholic Liver Disease
Kawaratani, H., Tsujimoto, T., Douhara, A., Takaya, H., Moriya, K., Namisaki, T., Noguchi, R., Yoshiji, H., Fujimoto, M., & Fukui, H. (2013) · Mediators of Inflammation · doi:10.1155/2013/495156 · Cited by 256
Mihm, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103104 · Cited by 232
Innate Immune Programing by Endotoxin and Its Pathological Consequences
Morris, M. C., Gilliam, E. A., & Li, L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00680 · Cited by 224
Contribution of Gut Bacteria to Liver Pathobiology
Son, G., Kremer, M., & Hines, I. N. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/453563 · Cited by 183
Riva, A., Patel, V., Kurioka, A., Jeffery, H. C., Wright, G., Tarff, S., Shawcross, D., Ryan, J. M., Evans, A., Azarian, S., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314458 · Cited by 150
Dunagan, M., Chaudhry, K., Samak, G., & Rao, R. K. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00526.2011 · Cited by 103
“5 evidence indicates that ethanol consumption induces intestinal epithelial barrier dysfunction and increased gut permeability leading to endotoxemia in human subjects and experimental animals (27, 28, 31).”
BackgroundSelf-citationMicrobiota, a key player in alcoholic liver disease
Cassard, A.-M., & Ciocan, D. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0067 · Cited by 100
Role of the gut in visceral fat inflammation and metabolic disorders
Lam, Y. Y., Mitchell, A. J., Holmes, A. J., Denyer, G. S., Gummesson, A., Caterson, I. D., Hunt, N. H., & Storlien, L. H. (2011) · Obesity · doi:10.1038/oby.2011.68 · Cited by 97
The unfolding web of innate immune dysregulation in alcoholic liver injury
Szabo, G., Mandrekar, P., Petrasek, J., & Catalano, D. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01398.x · Cited by 82
Immunoglobulin A and liver diseases
Inamine, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1400-8 · Cited by 76
Ballway, J. W., & Song, B.-J. (2021) · Antioxidants · doi:10.3390/antiox10030384 · Cited by 72
Elamin, E., Masclee, A., Dekker, J., & Jonkers, D. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00236.2013 · Cited by 72
Lipopolysaccharide enhances TGF‐β1 signalling pathway and rat pancreatic fibrosis
Sun, L., Xiu, M., Wang, S., Brigstock, D. R., Li, H., Qu, L., & Gao, R. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13526 · Cited by 63
Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease
Jia, L., Chang, X., Qian, S., Liu, C., Lord, C. C., Ahmed, N., Lee, C. E., Lee, S., Gautron, L., Mitchell, M. C., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.015 · Cited by 54
Immunology in alcoholic liver disease
Duddempudi, A. T. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.08.003 · Cited by 47
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A., & Rom, O. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1116861 · Cited by 40
Lee, J. S., O’Connell, E. M., Pacher, P., & Lohoff, F. W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081758 · Cited by 31
Pan, X.-Y., Wang, L., You, H.-M., Cheng, M., Yang, Y., Huang, C., & Li, J. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00531-7 · Cited by 26
Metadata
- Authors
- Rao, R.
- Venue
- Hepatology
- Published
- 2009-08
- Volume
- 50
- Issue
- 2
- Pages
- 638-644
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2057607705
- Cited by
- 470
- References
- 68
- FWCI
- 11.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.